In a statement drugmaker AstraZeneca said, a three-dose course of COVID-19 vaccine is effective against the Omicron variant of the coronavirus, citing data from an Oxford University lab study. The results of the study, which is yet to be published… Read More ›
hospitalisations
Merck & Co Inc and Ridgeback Biotherapeutics creates game changing COVID19 antiviral pill
Britain has become the first country in the world to approve a potential game-changing COVID-19 antiviral pill, which was jointly developed by US based Merck & Co Inc and Ridgeback Biotherapeutics, in its effort to fight the Wuhan Coronavirus. Britain’s Medicines… Read More ›